The outlook of companies tied to iconic drugs like Viagra presents a complex investment scenario . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the patent expiration in key territories has introduced considerable uncertainty . Investors are now assessing the impact of rival medicatio